Synlogic Lands $5,000,000 Series A Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    25 First Street Cambridge, MA 02141 USA
  • Company Description
    Synlogic leverages the most advanced technology platform available for the creation of synthetically engineered, therapeutic microbes with the potential to make significant advancements in the treatment of disease.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Along with developing its technology platform and proprietary therapeutic applications, Synlogic will collaborate with the Gates Foundation on applications relevant to the developing world.
  • M&A Terms
  • Venture Investor

Trending on Xconomy